Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer
about
Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer.Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-AnalysisClinical implications of molecular heterogeneity in triple negative breast cancer.nab-Paclitaxel for the treatment of breast cancer: an update across treatment settingsNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis.Anticancer effects of liriodenine on the cell growth and apoptosis of human breast cancer MCF-7 cells through the upregulation of p53 expressionNeoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.Recombinant nanocomposites by the clinical drugs of Abraxane® and Herceptin® as sequentially dual-targeting therapeutics for breast cancer.Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
P2860
Q35185733-D1ABC1B3-A790-458E-BC9E-44872CCC93EAQ36118278-B2D3FA27-16BB-4496-AAC9-0A3A7805C7C9Q36271396-0BB6702E-62F6-4E66-BA20-DCAD3579B81EQ37715554-4FBA9E8F-DE82-40AD-BE57-AA0043022A55Q37725620-4C974E2E-56A2-4C26-B1DC-D9EDA70F83C9Q41144868-89AF7EE8-1812-4A5B-AC8F-B9084D1D2D4FQ49303842-A9B1B4A1-303A-498A-8F7A-A7030FA1A7D4Q50333939-D0831126-DB15-4BFB-9CC6-6EC87D344CC9Q53008476-C7D3FFCC-8681-4D28-B2FE-CA7006D2156A
P2860
Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@ast
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@en
type
label
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@ast
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@en
prefLabel
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@ast
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@en
P2093
P2860
P921
P1476
Phase II trial of neoadjuvant ...... II HER2-negative breast cancer
@en
P2093
Bhuvaneswari Ramaswamy
Charles L Shapiro
Ewa Mrózek
Maryam Lustberg
Michael V Knopp
Rachel Layman
P2860
P304
P356
10.1016/J.CLBC.2014.02.005
P407
P577
2014-02-20T00:00:00Z